Title: Prevalence of desloratadine poor metabolizer phenotype in healthy Jordanian males.
Journal: Biopharmaceutics & drug disposition 20120101
Title: Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
Journal: Clinical therapeutics 20080901
Title: Simultaneous determination of desloratadine and its active metabolite 3-hydroxydesloratadine in human plasma by LC/MS/MS and its application to pharmacokinetics and bioequivalence.
Journal: Journal of pharmaceutical and biomedical analysis 20071130
Title: Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: a single-dose, randomized, open-label, two-way crossover study.
Journal: Clinical therapeutics 20070501
Title: Orthogonal extraction/chromatography and UPLC, two powerful new techniques for bioanalytical quantitation of desloratadine and 3-hydroxydesloratadine at 25 pg/mL.
Journal: Journal of pharmaceutical and biomedical analysis 20060224
Title: Pharmacokinetics/pharmacodynamics of desloratadine and fluoxetine in healthy volunteers.
Journal: Journal of clinical pharmacology 20041101
Title: Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3-hydroxydesloratadine.
Journal: Biopharmaceutics & drug disposition 20040901
Title: Validation of a sensitive and automated 96-well solid-phase extraction liquid chromatography-tandem mass spectrometry method for the determination of desloratadine and 3-hydroxydesloratadine in human plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030725
